Newly approved novel coronavirus test gives results in 45 minutes
The Food and Drug Administration approved the first rapid test for the novel coronavirus over the weekend. The test, made by the biotechnology company Cepheid, returns results in around 45 minutes and does not need to be processed in a lab.
But the test should primarily be used in emergency rooms and hospitals, not in doctors’ offices, David Persing, chief medical officer of Cepheid, told Stat News. In a hospital, it could help streamline care for sick people — knowing someone has or does not have COVID-19 quickly will let doctors decide how much protective equipment is needed to treat them, for example. “This is not a test for the worried well,” Persing said.
Machines that run the new Cepheid tests are already in some health care facilities in the US. Like the tests already in use at public health labs and hospitals, this new test looks for bits of the virus in patient samples. The company says it will start shipping tests this week.
After a long, costly delay, the US is finally testing tens of thousands of people a week for the novel coronavirus. Those tests, though, require that doctors swab a patient’s nose or throat and send that sample off to a lab with specialized equipment and technicians. At the fastest, turnaround time can take a few hours; in the US today, it’s taking days to receive test results.
Tests that can be run outside of a lab and can give doctors answers quickly are critical in the fight against a fast-spreading pandemic virus like the novel coronavirus. Engineers have the technology for rapid testing, but it’s not as widespread or well-established as the slow methods labs are relying on to test people who suspect they have COVID-19. For example, there are only around 5,000 Cepheid systems in use in the US — the systems that run the standard, slower tests are much more ubiquitous.
Testing, Testing, Testing: We must widely test our population, diagnose mild and even asymptomatic cases. Requires point of care diagnostics in doctor’s office. We must advance these immediately to market. It means serology to know who was exposed and developed immunity. 9/n
— Scott Gottlieb, MD (@ScottGottliebMD) March 21, 2020
Testing in the US needs to expand even more than it has been, and be done more quickly, in order to bring the pandemic under control. Systems like Cepheid’s that bring tests out of the lab, even though they’re limited, are an important step toward that goal.
The Food and Drug Administration approved the first rapid test for the novel coronavirus over the weekend. The test, made by the biotechnology company Cepheid, returns results in around 45 minutes and does not need to be processed in a lab. But the test should primarily be used in emergency…
Recent Posts
- As Google’s antitrust trial wraps, DOJ seeks sanctions over missing messages
- Microsoft needs some time to ‘refine’ updates for Copilot AI in Windows
- Sony Xperia 1 VI leak reveals new camera app and more features borrowed from Alpha cameras
- Quordle today – hints and answers for Saturday, May 4 (game #831)
- Google bans advertisers from promoting deepfake porn services
Archives
- May 2024
- April 2024
- March 2024
- February 2024
- January 2024
- December 2023
- November 2023
- October 2023
- September 2023
- August 2023
- July 2023
- June 2023
- May 2023
- April 2023
- March 2023
- February 2023
- January 2023
- December 2022
- November 2022
- October 2022
- September 2022
- August 2022
- July 2022
- June 2022
- May 2022
- April 2022
- March 2022
- February 2022
- January 2022
- December 2021
- November 2021
- October 2021
- September 2021
- August 2021
- July 2021
- June 2021
- May 2021
- April 2021
- March 2021
- February 2021
- January 2021
- December 2020
- November 2020
- October 2020
- September 2020
- August 2020
- July 2020
- June 2020
- May 2020
- April 2020
- March 2020
- February 2020
- January 2020
- December 2019
- November 2019
- December 2011